Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.
|
The Johns Hopkins University School of Medicine / Heather Symons |
Young Investigator Grants |
2009 |
Maryland |
Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia |
Children’s Hospital of Philadelphia / Jennifer Wilkes, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Kathryn Roberts, PhD |
Young Investigator Grants |
2013 |
Tennessee |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |
The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Ting Tao, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells |
University of California Berkeley / Erin Simonds, PhD |
Young Investigator Grants |
2013 |
California |